BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24446157)

  • 1. Estrogen withdrawal from osteoblasts and osteocytes causes increased mineralization and apoptosis.
    Brennan MÁ; Haugh MG; O'Brien FJ; McNamara LM
    Horm Metab Res; 2014 Jul; 46(8):537-45. PubMed ID: 24446157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4.
    Ahuja SS; Zhao S; Bellido T; Plotkin LI; Jimenez F; Bonewald LF
    Endocrinology; 2003 May; 144(5):1761-9. PubMed ID: 12697681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
    Wiren KM; Toombs AR; Semirale AA; Zhang X
    Bone; 2006 May; 38(5):637-51. PubMed ID: 16413235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen plus estrogen receptor antagonists alter mineral production by osteoblasts in vitro.
    Brennan O; O'Brien FJ; McNamara LM
    Horm Metab Res; 2012 Jan; 44(1):47-53. PubMed ID: 22124881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of an osteoid preosteocyte-like cell MLO-A5 that spontaneously mineralizes in culture.
    Kato Y; Boskey A; Spevak L; Dallas M; Hori M; Bonewald LF
    J Bone Miner Res; 2001 Sep; 16(9):1622-33. PubMed ID: 11547831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.
    Posritong S; Hong JM; Eleniste PP; McIntyre PW; Wu JL; Himes ER; Patel V; Kacena MA; Bruzzaniti A
    Mol Cell Endocrinol; 2018 Oct; 474():35-47. PubMed ID: 29428397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 alters osteocyte signaling toward osteoblasts but not osteoclasts.
    Bakker AD; Kulkarni RN; Klein-Nulend J; Lems WF
    J Dent Res; 2014 Apr; 93(4):394-9. PubMed ID: 24492932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an osteocyte-like cell line, MLO-Y4.
    Kato Y; Windle JJ; Koop BA; Mundy GR; Bonewald LF
    J Bone Miner Res; 1997 Dec; 12(12):2014-23. PubMed ID: 9421234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts.
    Heino TJ; Hentunen TA; Väänänen HK
    Exp Cell Res; 2004 Apr; 294(2):458-68. PubMed ID: 15023534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ageing, prolonged estrogen deficiency and zoledronate on bone tissue mineral distribution.
    Brennan MA; Gleeson JP; O'Brien FJ; McNamara LM
    J Mech Behav Biomed Mater; 2014 Jan; 29():161-70. PubMed ID: 24090875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
    J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strontium ranelate affects signaling from mechanically-stimulated osteocytes towards osteoclasts and osteoblasts.
    Bakker AD; Zandieh-Doulabi B; Klein-Nulend J
    Bone; 2013 Mar; 53(1):112-9. PubMed ID: 23234812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteocyte biology: its implications for osteoporosis.
    Bonewald LF
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):101-4. PubMed ID: 15615083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ugonin K-stimulated osteogenesis involves estrogen receptor-dependent activation of non-classical Src signaling pathway and classical pathway.
    Lee CH; Huang YL; Liao JF; Chiou WF
    Eur J Pharmacol; 2012 Feb; 676(1-3):26-33. PubMed ID: 22192930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sanguis Draconis resin stimulates osteoblast alkaline phosphatase activity and mineralization in MC3T3-E1 cells.
    Wang W; Olson D; Cheng B; Guo X; Wang K
    J Ethnopharmacol; 2012 Jun; 142(1):168-74. PubMed ID: 22543168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of estrogen in the control of rat osteocyte apoptosis.
    Tomkinson A; Gevers EF; Wit JM; Reeve J; Noble BS
    J Bone Miner Res; 1998 Aug; 13(8):1243-50. PubMed ID: 9718192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-mediated mineralization of MC3T3-E1 osteoblast cultures.
    Nakano Y; Addison WN; Kaartinen MT
    Bone; 2007 Oct; 41(4):549-61. PubMed ID: 17669706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of fulvestrant, an estrogen receptor antagonist, on the proliferation, differentiation and mineralization of osteoprecursor cells.
    Park JB
    Mol Med Rep; 2013 Feb; 7(2):555-8. PubMed ID: 23179494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen deficiency attenuates fluid flow-induced [Ca
    Deepak V; Kayastha P; McNamara LM
    FASEB J; 2017 Jul; 31(7):3027-3039. PubMed ID: 28363954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studying osteocyte function using the cell lines MLO-Y4 and MLO-A5.
    Rosser J; Bonewald LF
    Methods Mol Biol; 2012; 816():67-81. PubMed ID: 22130923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.